Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Rhea-AI Summary

Revelation Biosciences Inc. (REVB) CEO, James Rolke, to participate in a virtual fireside chat at the 36th Annual Roth Conference. The event will take place on March 17-19, 2023, at The Ritz Carlton, Laguna Niguel, California.

SAN DIEGO--(BUSINESS WIRE)-- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation) a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced today that its Chief Executive Officer James Rolke will participate in a virtual fireside chat at the 36th Annual Roth Conference scheduled for March 17-19, 2023 to be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.

Details regarding the Revelation fireside chat are as follows:

35th Annual Roth Conference Presentation Details

Date:		Monday, March 18, 2023
Time:		11:00 a.m. Pacific Time
Location:		The Ritz Carlton, Laguna Niguel, CA
Webcast:		REVB Webcast Link

A live webcast of the presentation will also be available in the Investor Relations section of Revelation’s website at https://www.revbiosciences.com. A replay of the presentation will be available on Revelation’s website for 30 days following the event.

Mr. Rolke will be available for one-on-one meetings throughout the conference in person and virtually.

About Revelation Biosciences Inc.

Revelation Biosciences, Inc. is a life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation, Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including GEMINI-SSI as a prevention for post-surgical infection, GEMINI-AKI as a prevention for acute kidney injury, and GEMINI-CKD for the treatment of chronic kidney disease.

For more information on Revelation, please visit www.RevBiosciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312834070/en/

Sandra Vedrick

Vice President, Investor Relations & Human Resources

Revelation Biosciences Inc.

Email: svedrick@revbiosciences.com

and

Chester Zygmont, III

Chief Financial Officer

Revelation Biosciences Inc.

Email: czygmont@revbiosciences.com

Source: Revelation Biosciences Inc.

FAQ

When will the CEO of Revelation Biosciences participate in a virtual fireside chat at the 36th Annual Roth Conference?

The CEO, James Rolke, will participate in the virtual fireside chat at the 36th Annual Roth Conference scheduled for March 17-19, 2023.

Where will the 36th Annual Roth Conference be held?

The 36th Annual Roth Conference will be held at The Ritz Carlton, Laguna Niguel in Dana Point, California.

Will there be a live webcast of the presentation?

Yes, a live webcast of the presentation will be available in the Investor Relations section of Revelation's website.

For how long will a replay of the presentation be available on Revelation's website?

A replay of the presentation will be available on Revelation's website for 30 days following the event.

Will Mr. Rolke be available for one-on-one meetings during the conference?

Yes, Mr. Rolke will be available for one-on-one meetings throughout the conference in person and virtually.